Annual Report

Overview

The report describes Diaceutics' strong 2022 performance, with revenue rising 40% to £19.5m and year-end headcount increasing to 151. The DXRX platform expanded its reach, including growth in platform-enabled revenue and the lab network. The company also established an ESG working group and began reporting operational environmental metrics, including 140,600 kWh of electricity use and 46% renewable sourcing at its Belfast headquarters.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: Ends 31 December 2022
Publication date: 1 April 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services